Canada markets close in 35 minutes

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.04200.0000 (0.00%)
At close: 02:31PM AEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Operating Expenses
Research Development
1,602
1,602
747.181
840.815
1,289
Selling General and Administrative
891.44
891.44
1,376
1,620
1,991
Total Operating Expenses
3,285
3,285
3,022
3,113
4,206
Operating Income or Loss
-3,285
-3,285
-3,022
-3,113
-4,206
Interest Expense
2.37
2.37
3.32
0.3
-
Total Other Income/Expenses Net
1,246
1,246
487.235
1,108
789.211
Income Before Tax
-2,023
-2,023
-2,532
-1,996
-3,365
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-2,023
-2,023
-2,532
-1,996
-3,365
Net Income
-2,023
-2,023
-2,532
-1,996
-3,365
Net Income available to common shareholders
-2,023
-2,023
-2,532
-1,996
-3,365
Basic EPS
-0.02
-
-0.03
-0.03
-0.06
Diluted EPS
-0.02
-
-0.03
-0.03
-0.06
Basic Average Shares
104,303
-
78,218
68,953
54,616
Diluted Average Shares
104,303
-
78,218
68,953
54,616